Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB1 | P05556 | 9/20 | 0.44 |
| ▸ | ITGA4 | P13612 | 9/20 | 0.44 |
| ▸ | ELANE | P08246 | 1/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.31 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.30 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3836314 | 1.00 | ITGB1 (0.44) | ITGB1ITGA4ELANEPTGS2CYP3A4 | |
| SCHEMBL3836401 | 0.93 | ITGB1 (0.51) | ITGB1ITGA4CYP3A4CYP2C9 | |
| SCHEMBL3836794 | 0.93 | ITGA4 (0.43) | ITGB1ITGA4ELANEPTGS2CYP3A4 | |
| SCHEMBL2988304 | 0.92 | ITGB1 (0.50) | ITGB1ITGA4CYP3A4CYP2C9 | |
| SCHEMBL6131650 | 0.92 | ITGB1 (0.50) | ITGB1ITGA4CYP3A4CYP2C9 | |
| SCHEMBL3833591 | 0.89 | ITGB1 (0.40) | ITGB1ITGA4ELANECYP3A4CYP2C9 | |
| SCHEMBL2976280 | 0.85 | ITGB1 (0.48) | ITGB1ITGA4CYP3A4CYP2C9 | |
| SCHEMBL5179350 | 0.85 | ITGB1 (0.48) | ITGB1ITGA4CYP3A4CYP2C9 | |
| SCHEMBL3884133 | 0.85 | ITGB1 (0.58) | ITGB1ITGA4CYP3A4CYP2C9 | |
| SCHEMBL2978337 | 0.85 | ITGB1 (0.58) | ITGB1ITGA4CYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6951943-B2 | Process for the preparation of phenylalanine enamide derivatives | CELLTECH R & D LIMITED (GB) | 2005-10-04 | — | — | US | disclosed |
| US-20040073033-A1 | Process for the preparation of phenylalanine enamide derivatives | UCB PHARMA S.A. (BE) | 2004-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040073033-A1 | Process for the preparation of phenylalanine enamide derivatives | NPY2R, NPY1R, NPR1 | ITGB1 4148/4885ITGA4 3960/4885ELANE 855/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.